Skip to main content
SpringerLink
Log in
Book cover

Peritoneale Tumoren und Metastasen pp 63–71Cite as

Induktive präoperative Chemotherapie bei peritonealen Metastasen von Tumoren des oberen GI-Trakts

  • Chapter

  • 1620 Accesses

Zusammenfassung

Dieses Kapitel konzentriert sich auf peritoneale Metastasen des Magenkarzinoms. In den aktuellen deutschen Leitlinien zum Magenkarzinom wird die intraperitoneale Chemotherapie und hyperthermer intraperitonealer Chemoperfusion (HIPEC) bisher nicht außerhalb von Studien empfohlen. Die Leitlinien werden jedoch aktuell überarbeitet, und eine Änderung dieser Empfehlung in Zukunft ist möglich, da es immer mehr Erfahrungen mit Peritonektomie und HIPEC auch beim Magenkarzinom gibt.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   139.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Al-Batran SE, Hartmann JT, Hofheinz R, Homann N, Rethwisch V, Probst S, Stoehlmacher J, Clemens MR, Mahlberg R, Fritz M, Seipelt G, Sievert M, Pauligk C, Atmaca A, Jäger E (2008) Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 19: 1882–1887

    Article  PubMed  Google Scholar 

  • Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, Meiler J, Homann N, Lorenzen S, Schmalenberg H, Probst S, Koenigsmann M, Egger M, Prasnikar N, Caca K, Trojan J, Martens UM, Block A, Fischbach W, Mahlberg R, Clemens M, Illerhaus G, Zirlik K, Behringer DM, Schmiegel W, Pohl M, Heike M, Ronellenfitsch U, Schuler M, Bechstein WO, Königsrainer A, Gaiser T, Schirmacher P, Hozaeel W, Reichart A, Goetze TO, Sievert M, Jäger E, Mönig S, Tannapfel A (2016a) Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial. Lancet Oncol pii: S1470–S2045(16) 30531–9 doi: 10.1016/S1470–2045(16)30531–9

  • Al-Batran SE, Schuler MH, Zvirbule Z, Manikhas G, Lordick F, Rusyn A, Vynnyk Y, Vynnychenko I, Fadeeva N, Nechaeva M, Dudov A, Gotovkin E, Pecheniy A, Bazin I, Bondarenko I, Melichar B, Mueller C, Huber C, Tureci O, Sahin U; FAST (2016b) An international, multicenter, randomized, phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without IMAB362, a first-in-class anti-CLDN18.2 antibody, as first-line therapy in patients with advanced CLDN18.2+ gastric and gastroesophageal junction (GEJ) adenocarcinoma. J Clin Oncol 34 (Suppl): abstr LBA4001

    Google Scholar 

  • Al-Batran SE, Homann N, Schmalemberg H, et al. (2017) Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): a multicenter, randomized phase 3 trial. J Clin Oncol 35 (Suppl): abstr 4004

    Google Scholar 

  • Alderson D, Langley RE, Nankivell MG, Blazeby JM, Griffin M, Crellin A, Grabsch HI, Okines AFC, Goldstein C, Falk S, Thompson J, Krysztopik R, Coxon FY, Pritchard S, Langer R, Stenning SP, Cunningham D (2015) Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK Medical Research Council randomised OEO5 trial (ISRCTN 01852072) J Clin Oncol 33 (Suppl) abstr 4002

    Google Scholar 

  • Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27: 5062–5067

    Article  PubMed  Google Scholar 

  • Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK (2010) ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. Lancet 376: 687–697

    Google Scholar 

  • Baron MA (1941) Structure of intestinal peritoneum in man. Am J Anat, 69: 439–497

    Google Scholar 

  • Coccolini F, Catena F, Glehen O, et al. (2015) Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cutoff. Systemic review and meta-analysisn. Eur J Surg Oncol 41: 911–919. doi.org/10.1016/j.ejso.2015.03.231

    Article  CAS  Google Scholar 

  • Cunningham D, Smyth E, Stenning S, et al. (2015) Peri-operative chemotherapy +/- bevacizumab for resectable gastro-oesophageal adenocarcinoma: Results from the UK Medical Research Council randomised ST03 trial (ISRCTN 46020948). Eur J Cancer 51: 400

    Article  Google Scholar 

  • Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ (2006) MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11–20

    Article  CAS  Google Scholar 

  • Cunningham D, Starling N, Rao S, et al. (2008) Capecitabine and oxaliplatin for advanced esophagogastric cancer. N Engl J Med 358: 36–46

    Article  CAS  Google Scholar 

  • de Bree E, Tsiftsis DD (2007) Experimental and pharmacologic studies in intraperitoneal chemotherapy from laboratory bench to bedside. In: Gonzalez-Moleno S (ed) Advances in peritoneal surface oncology. Springer, Heidelberg, S 53–73

    Chapter  Google Scholar 

  • Downs-Canner S, Ding Y, Magge DR, Jones H, Ramalingam L, Zureikat A, Holtzman M, Ahrendt S, Pingpank J, Zeh HJ, Bartlett DL, Choudry HA. A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion. Ann Surg Oncol 22: 1651–1657. doi: 10.1245/s10434–014–4186–4

  • Glehen O, Schreiber V, Cotte E, et al. (2004) Cytoreductive surgery and intraperitoneal chemohyerthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 139: 20–26

    Article  CAS  PubMed  Google Scholar 

  • Glehen O, Gilly FN, Arvieux C, et al. (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17: 2370–2377. http://dx.doi.org/10.1245/s10434–010–1039–7

    Article  PubMed  Google Scholar 

  • Hofheinz R, Hegewisch-Becker S, Thuss-Patience PC, Kunzmann V, Fuchs M, Graeven U, Homann N, Heinemann V, Pohl M, Tannapfel A, Al-Batran SE (2014) HER-FLOT: Trastuzumab in combination with FLOT as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study Group. J Clin Oncol 32 (Suppl): abstr 4073

    Google Scholar 

  • Imamoto H1, Oba K, Sakamoto J, Iishi H, Narahara H, Yumiba T, Morimoto T, Nakamura M, Oriuchi N, Kakutani C, Morita S, Shiozaki H (2011) Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer. Gastric Cancer 14: 81–90. doi: 10.1007/s10120–011–0016–6

  • Ishigami H, Kitayama J, Kaisaki S, et al. (2010) Phase II study of weekly intravenous and intraperitoneal paclitaxel (PTX) combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol 21: 67–70. http://dx.doi.org/10.1093/annonc/mdp260

  • Kelsen DP, Ginsberg R, Pajak TF, et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339: 1979–1984

    Article  CAS  Google Scholar 

  • Kelsen DP, Winter KA, Gunderson LL, et al. (2007) Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 25: 3719–3725

    Article  PubMed  Google Scholar 

  • Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IH, Punt CJ (2012) Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol 38: 617–623. doi: 10.1016/j.ejso.2012.03.008

    Article  CAS  Google Scholar 

  • Lorenzen S, Hentrich M, Haberl C, Heinemann V, Schuster T, Seroneit T, Roethling N, Peschel C, Lordick F (2007) Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Ann Oncol 18: 1673–1679

    Article  CAS  PubMed  Google Scholar 

  • Moehler M, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D, Baier P, Baretton G, Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C; AWMF; AWMF (eds) (2011) German S3-guideline «Diagnosis and treatment of esophagogastric cancer». Z Gastroenterol 49: 461–531. doi: 10.1055/s-0031–1273201

  • Satoi S, Fujii T, Yanagimoto H, Motoi F, Kurata M, Takahara N, Yamada S, Yamamoto T, Mizuma M, Honda G, Isayama H, Unno M, Kodera Y, Ishigami H, Kon M (2017) Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. Ann Surg 265: 397–401. doi: 10.1097/SLA.0000000000001705

    Article  PubMed  Google Scholar 

  • Schuhmacher C, Gretschel S, Lordick F, et al. (2010) Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. J Clin Oncol 28: 5210–5218

    Article  PubMed  PubMed Central  Google Scholar 

  • Seyfried F, von Rahden BH, Miras AD, Gasser M, Maeder U, Kunzmann V, Germer CT, Pelz J, Kerscher AG (2015) Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients. BMC Cancer 15: 73. doi: 10.1186/s12885–015–1081–8

  • Shah MA, Janjigian YY, Stoller R, Shibata S, Kemeny M, Krishnamurthi S, Su YB, Ocean A, Capanu M, Mehrotra B, Ritch P, Henderson C, Kelsen DP (2015) Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium. J Clin Oncol 33: 3874–3879

    Article  CAS  PubMed  Google Scholar 

  • Tentes AA, Kyziridis D, Kakolyris S, Pallas N, Zorbas G, Korakianitis O, Mavroudis C, Courcoutsakis N, Prasopoulos P (2012) Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Gastroenterol Res Pract 2012: 506571. doi: 10.1155/2012/506571

    Article  Google Scholar 

  • Thuss-Patience PC, Hofheinz RD, Arnold D, Florschütz A, Daum S, Kretzschmar A, Mantovani-Löffler L, Bichev D, Breithaupt K, Kneba M, Schumacher G, Glanemann M, Schlattmann P, Reichardt P, Gahn B (2012) Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Ann Oncol 23: 2827–2834. doi: 10.1093/annonc/mds129

    Article  CAS  PubMed  Google Scholar 

  • Van Cutsem E, Moiseyenko VM, Tjulandin S, et al. (2006) Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24: 4991–4997

    Google Scholar 

  • Yang XJ, Li Y, Yonemura Y (2010) Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: results from a Chinese center. J Surg Oncol 10: 457–464

    Article  PubMed  Google Scholar 

  • Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, Ducourtieux M, Bedenne L, Fabre JM, Saint-Aubert B, Genève J, Lasser P, Rougier P (2011) Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 29: 1715–1721. doi: 10.1200/JCO.2010.33.0597

    Article  CAS  PubMed  Google Scholar 

  • Yonemura Y, Endou Y, Shinbo M, et al. (2009) Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery. J Surg Oncol 15: 311–316. doi.org/10.1002/jso.21324

    Article  CAS  PubMed  Google Scholar 

  • Yonemura Y, Elnemr A, Endou Y, et al. (2010) Multidisciplinary therapy for treatment of peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol: 85–97. doi.org/10.4251/wjgo.v2.i2.85

  • Yonemura Y, Canbay E, Endou Y, et al. (2014) A new bidirectional intraperitoneal and systemic induction chemotherapy (BISIC) for the peritoneal metastasis from gastric cancer in neoadjuvant setting. Integr Cancer Sci Ther Integr Cancer Sci Ther 1: 26–29. http://dx.doi.org/10.15761/ICST.1000106

  • Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem H (2016) A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. Eur J Surg Oncol 42: 1123–1131. doi: 10.1016/j.ejso.2016.03.016

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Charité Universitätsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik m.S. Hämatologie, Onkologie und Tumorimmunologie, Augustenburger Platz 1, 13353, Berlin, Deutschland

    PD Dr. med. P. Thuss-Patience

Authors
  1. PD Dr. med. P. Thuss-Patience
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P. Thuss-Patience .

Editor information

Editors and Affiliations

  1. Charité Campus Virchow-Klinikum, Berlin, Deutschland

    Beate Rau

  2. Krankenhaus Barmherzige Brüder, Regensburg, Deutschland

    Pompiliu Piso

  3. Universitätsklinikum Tübingen, Tübingen, Deutschland

    Alfred Königsrainer

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Thuss-Patience, P. (2018). Induktive präoperative Chemotherapie bei peritonealen Metastasen von Tumoren des oberen GI-Trakts. In: Rau, B., Piso, P., Königsrainer, A. (eds) Peritoneale Tumoren und Metastasen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54500-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54500-3_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54499-0

  • Online ISBN: 978-3-662-54500-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation